Literature DB >> 30128833

Estimation of the Direct Cost of Poliomyelitis Rehabilitation Treatment to Pakistani Patients: A 53-Year Retrospective Study.

Atta Abbas Naqvi1, Syed Baqir Shyum Naqvi2, Fatima Zehra3, Ashutosh Kumar Verma4, Saman Usmani5, Sehrish Badar2, Rizwan Ahmad6, Niyaz Ahmad7.   

Abstract

BACKGROUND: Pakistan is one of the last few countries in which poliomyelitis is endemic. Evidence indicates that out-of-pocket expenditures are a barrier to polio rehabilitation treatment, yet there are no reported figures related to the financial burden of this disease on patients in a recently polio-endemic country.
OBJECTIVE: This study investigated direct costs attributed to rehabilitation treatment of poliomyelitis among Pakistani patients and reported its duration along with the socioeconomic status of poliomyelitis survivors.
CONCLUSION: The cost of poliomyelitis rehabilitation in Pakistan is high; it has an economic effect on the lives of patients and their families. Despite good education, polio survivors in Pakistan appear to have low socioeconomic status, lower chances of employment and marriage, as well as fewer children. Further research is recommended to explore the burden of disease on society, i.e., indirect costs and suffering.

Entities:  

Mesh:

Year:  2018        PMID: 30128833     DOI: 10.1007/s40258-018-0422-6

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN: 1175-5652            Impact factor:   2.561


  8 in total

1.  Validation of the General Medication Adherence Scale in Pakistani Patients With Rheumatoid Arthritis.

Authors:  Atta Abbas Naqvi; Mohamed Azmi Hassali; Mehwish Rizvi; Ale Zehra; Zeb-Un- Nisa; Md Ashraful Islam; Muhammad Shahid Iqbal; Maryam Farooqui; Mohammad Tarique Imam; Mohammad Akbar Hossain; Irfanullah Khan; Muhammad Zahid Iqbal; Majid Ali; Abdul Haseeb
Journal:  Front Pharmacol       Date:  2020-07-17       Impact factor: 5.810

2.  Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru.

Authors:  Janice Seinfeld; María Laura Rosales; Alfredo Sobrevilla; Juan Guillermo López Yescas
Journal:  BMC Health Serv Res       Date:  2022-05-16       Impact factor: 2.908

3.  Pharmacists' viewpoint towards their professional role in healthcare system: a survey of hospital settings of Pakistan.

Authors:  Nabeel Khan; Ken McGarry; Atta Abbas Naqvi; Muhammad Shahid Iqbal; Zaki Haider
Journal:  BMC Health Serv Res       Date:  2020-07-02       Impact factor: 2.655

4.  Impact of pharmacist educational intervention on disease knowledge, rehabilitation and medication adherence, treatment-induced direct cost, health-related quality of life and satisfaction in patients with rheumatoid arthritis: study protocol for a randomized controlled trial.

Authors:  Atta Abbas Naqvi; Mohamed Azmi Hassali; Syed Baqir Shyum Naqvi; Muhammad Tariq Aftab
Journal:  Trials       Date:  2019-08-09       Impact factor: 2.279

5.  Development and validation of the General Rehabilitation Adherence Scale (GRAS) in patients attending physical therapy clinics for musculoskeletal disorders.

Authors:  Atta Abbas Naqvi; Mohamed Azmi Hassali; Syed Baqir Shyum Naqvi; Sadia Shakeel; Madiha Zia; Mustajab Fatima; Wajiha Iffat; Irfanullah Khan; Amnah Jahangir; Muhammad Nehal Nadir
Journal:  BMC Musculoskelet Disord       Date:  2020-02-01       Impact factor: 2.362

6.  Development and Validation of a Novel General Medication Adherence Scale (GMAS) for Chronic Illness Patients in Pakistan.

Authors:  Atta Abbas Naqvi; Mohamed Azmi Hassali; Mehwish Rizvi; Ale Zehra; Wajiha Iffat; Abdul Haseeb; Shazia Jamshed
Journal:  Front Pharmacol       Date:  2018-10-09       Impact factor: 5.810

7.  Translation and validation of the English version of the general medication adherence scale (GMAS) in patients with chronic illnesses.

Authors:  Atta Abbas Naqvi; Mohamed Azmi Hassali; Amnah Jahangir; Muhammad Nehal Nadir; Bharti Kachela
Journal:  J Drug Assess       Date:  2019-02-06

8.  Assessment of Medication Adherence in Saudi Patients With Type II Diabetes Mellitus in Khobar City, Saudi Arabia.

Authors:  Khaled AlQarni; Elham A AlQarni; Atta Abbas Naqvi; Dhfer Mahdi AlShayban; Syed Azizullah Ghori; Abdul Haseeb; Mohamed Raafat; Shazia Jamshed
Journal:  Front Pharmacol       Date:  2019-11-08       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.